Key Takeaways Digital investments and capital allocation enhance efficiency, margin expansion, and strengthen Cencora's competitive edge amid regulatory and industry shifts. Specialty drug demand, aging populations, and targeted acquisitions support sustained revenue growth and long-term earnings resilience.